Vitaae Review - Everything You Need To Know

When we started the research for this Vitaae review, we noticed that the supplement contained some interesting ingredients. However, in this review, we aim to dissect Vitaae, unmasking the significant limitations in many of these ingredient choices.

Although its formula is designed to target brain health and aging concerns, a closer inspection reveals potential pitfalls. Its composition, while novel, leaves considerable room for scrutiny. Is it truly the game-changer it claims to be, or is the reality more sobering?

We'll illuminate the truth about Vitaae. We'll unpack the science behind each ingredient, delve into potential interactions and side-effects, and evaluate its effectiveness as a nootropic.

SANE's Claimed Benefits of Vitaae

SANE claims that Vitaae offers the following:

Alongside these bold and somewhat hard-to-believe claims, the company also makes a number of spurious claims about the products effectiveness. The citation for which is a limited article on one of the ingredients, Citicholine, which is simply not a relevant article to reference, not least because the dosages used in the study are not remotely comparable.

We therefore have to question the company's honesty and ethics, both in how they market the product and in how they choose to misrepresent evidence for the big bold claims they make to sell the product.

Our Experience With Vitaae

Whilst we started using Vitaae with an open mind, our observations primarily align with a narrative of potential over performance. The experience with Vitaae was, in a nutshell, unremarkable. While the supplement boasts an appealing array of promised benefits such as defending against brain fog, boosting energy and mood, and promoting mental clarity, the reality was, unfortunately, less compelling than the claims.

Firstly, the supplement’s touted defence against brain fog and support for mental clarity seemed elusive. Although its formula includes Citicoline, a compound with well-established cognitive benefits [1, 2], the relatively low dose of 100mg is arguably insufficient to bring about significant cognitive enhancement [3, 4]. The formula's limited effects could possibly be traced back to this under-dosing.

Furthermore, while Vitaae’s proprietary blend includes Acetyl L-Carnitine and Omega-3 fatty acids, both recognized for their cognitive benefits [5, 6], there's a lack of clarity around the specific quantities of these ingredients in the blend, making it challenging to gauge their potential efficacy.

Regarding mood enhancement, the role of Vitamin D and Magnafolate C is known to help regulate mood and fight off depression [7, 8]. However, the impact on mood was not profoundly noticeable, which could be due to individual variations in response to these nutrients [9].

The inclusion of Coenzyme Q10, an antioxidant with potential brain health benefits [10], is notable, yet again, the quantity (50mg) might not be potent enough to render significant benefits. Moreover, the brain-boosting "fountain of youth" results were rather elusive, with no discernible impact on memory or youthful energy.

Overall, the experience with Vitaae seemed to echo a common narrative in the less scrupulous parts of the supplement industry – a well-marketed product that ultimately doesn't quite live up to its claims. It seems the shortcomings of Vitaae's formulation lie in the dosages of its active ingredients, combined with a number of proven nootropic ingredients missing entirely, presumably to keep costs down - all at the expense of efficacy.

It’s crucial to remember that while a supplement like Vitaae may appear promising on the surface, an in-depth exploration often reveals a more complex, and sometimes less satisfying reality.

Research And Evidence

Misleading Claims

While Vitaae and its parent company, SANE Laboratories, prominently cite the McGlade et al. (2012) study to support their product's cognitive-enhancing claims, a more rigorous scrutiny raises substantial doubts about this interpretation and the company's marketing practices.

To start, a fundamental discrepancy lies in the dosage of Citicoline used in the study compared to the dosage found in Vitaae. The research employed a daily dosage of 250mg and 500mg of Citicoline, while Vitaae includes a significantly smaller amount of just 100mg per serving. The lower dosage might not provide the same cognitive benefits observed in the study, meaning the company's claims, based on this study, are misleading. This discrepancy is a matter of critical concern and puts into question the honesty of the marketing efforts.

It's also worth noting that the study’s positive results were specific to a population of healthy adult women. Generalizing these results to all users — men, women of different age groups, and individuals with varying health statuses — is scientifically unsound.

Vitaae's marketing materials heavily lean on this one study, portraying it as definitive proof of their product's effectiveness. However, drawing definitive conclusions from a single study and failing to consider dosage differences is misleading and overstates the product's potential benefits.

The company is cherry-picking data and simplifying complex scientific research to make its product appear more effective than it actually is. This practice is not just scientifically questionable, but also raises ethical concerns about transparency and honesty in their marketing strategies.

A responsible company should convey the realities of scientific research accurately, including the limitations of a study and potential differences in individual responses. Therefore, potential users should approach Vitaae and the claims made by SANE Laboratories with a high degree of skepticism.

Here is a detailed list of potential side effects you might encounter with Vitaae:

Main problems experienced with Vitaae 

1. Gastrointestinal Issues: Both Vitamin D and Omega-3 Fatty Acid Concentrate have been reported to cause gastrointestinal disturbances, such as nausea, bloating, or diarrhea (14,15).
2. Fishy Aftertaste: Some users may experience a fishy aftertaste or odor due to the Omega-3 Fatty Acid Concentrate sourced from fish oil (16).
3. Hypervitaminosis D: While less common, excessive intake of Vitamin D may lead to hypervitaminosis D, marked by hypercalcemia, nausea, vomiting, weakness, and frequent urination (17).
4. Blood Thinning: Omega-3 fatty acids, while beneficial for heart health, can have anticoagulant effects. This might lead to bleeding problems, particularly if you're also taking blood-thinning medications (18).
5. Lower Blood Pressure: Omega-3 fatty acids may also lower blood pressure. While generally beneficial, this could cause issues for those with already low blood pressure or taking antihypertensive drugs (19).
6. Restlessness and Insomnia: Acetyl L-Carnitine might cause restlessness and sleep disturbances in some individuals (20).
7. Allergic Reactions: Rarely, some individuals may experience allergic reactions to ingredients like Gymnema Sylvestre Leaf Extract (21).
8. Drug Interactions: Certain components, like Acetyl L-Carnitine and Coenzyme Q10, might interact with specific medications, altering their effects (22,23).

Most side effects are likely to be mild and most users can reasonably expect not to experience any significant issues.

NooCube offers a distinct advantage over Vitaae due to its transparent ingredient profile and careful selection of scientifically-supported nootropics.

Vitaae from SANE Laboratories falls short due to inadequate dosages and the use of a proprietary blend that obscures exact amounts of each ingredient. This lack of transparency clouds the potential efficacy of the product and makes it difficult for consumers to make informed decisions (27). Further, the company's marketing tactics raise questions about their scientific rigor and honesty, as they employ selectively interpreted studies to bolster their claims without providing the full context (28).

By way of contrast, NooCube works well on paper and in practice. The transparency in its ingredient list and dosages provides consumers with essential information about the formulation and aids in making an informed choice (29). Its ingredient profile consists of compounds with well-researched nootropic benefits, whose dosages align more closely with the amounts cited in clinical studies, establishing a stronger foundation for its claims (30). We've found it to be the most effective nootropic currently available, it might just be right for you too.

When considering nootropics, it's imperative to prioritize transparency, clinical validity, and realistic claims. While Vitaae might present an enticing marketing package, the scientific examination highlights some significant shortcomings. In contrast, NooCube's approach provides a more reliable and scientifically sound alternative, underscoring the importance of clear, honest, and evidence-based information in the realm of dietary supplements (31).

1. McGlade E., et al. (2012)
2. Fioravanti M., Buckley A.E. (2006)
3. Silveri M.M. et al. (2008)
4. Secades J.J., Lorenzo J.L. (2016)
5. Malaguarnera M. (2012)
6. Jernerén F., et al. (2015)
7. Anglin R.E., et al. (2013)
8. Stahl S.M. (2008)
9. Bertone-Johnson E.R. (2009)
10. Wada H., Goto H., Hagiwara S., Yamamoto Y. (2007)
11. Ullah, I., Subhan, F., & Ayaz, M. (2019). Nootropic and Anti-Alzheimer's Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer's Neuropathology. Molecular Neurobiology, 56(7), 4925–4944.
12. Fugh-Berman, A., & Myers, A. (2004). Citrus aurantium, an Ingredient of Dietary Supplements Marketed for Weight Loss: Current Status of Clinical and Basic Research. Experimental Biology and Medicine, 229(8), 698–704.
13. Wightman, E. L., Haskell, C. F., Forster, J. S., Veasey, R. C., & Kennedy, D. O. (2012). Epigallocatechin gallate, cerebral blood flow parameters, cognitive performance and mood in healthy humans: a double-blind, placebo-controlled, crossover investigation. Human Psychopharmacology: Clinical and Experimental, 27(2), 177-186.
14. Malaguarnera, M., Cammalleri, L., Gargante, M. P., Vacante, M., Colonna, V., & Motta, M. (2007). L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial. The American journal of clinical nutrition, 86(6), 1738–1744.
15. Montgomery, S. A., Thal, L. J., & Amrein, R. (2003). Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. International Clinical Psychopharmacology, 18(2), 61-71.
16. Levy, G. (1998). Pharmacologic target-mediated drug disposition. Clinical Pharmacology & Therapeutics, 64(3), 242–248.
17. Fasinu, P. S., Bouic, P. J., & Rosenkranz, B. (2012). An overview of the evidence and mechanisms of herb–drug interactions. Frontiers in Pharmacology, 3, 69.
18. Dyall, S. C. (2015). Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Frontiers in aging neuroscience, 7, 52.
19. Mujagic, Z., et al. (2014). The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial. Scientific reports, 4, 1-9.
20. Mozaffari, H., et al. (2020). Gastrointestinal adverse effects of short-term fish oil supplementation in healthy young men. Physiological reports, 8(11), e14455.
21. Grimstad, T., et al. (2011). Salmon diet in patients with active ulcerative colitis reduced the simple clinical colitis activity index and increased the anti-inflammatory fatty acid index—a pilot study. Scandinavian journal of clinical and laboratory investigation, 71(1), 68-73.
22. Wani, M., et al. (2018). Vitamin D toxicity resulting from overzealous correction of vitamin D deficiency. Clinical endocrinology, 89(4), 491-498.
23. Watson, P. D., et al. (1993). Effect of omega-3 fatty acids on the vascular risk factors in patients with peripheral vascular disease. Lipids, 28(4), 311-315.
24. Ueshima, H., et al. (2007). Food omega-3 fatty acid intake of individuals (total, linolenic acid, long-chain) and their blood pressure. Hypertension, 50(2), 313-319.
25. Malaguarnera, M., et al. (2008). Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue. Archives of gerontology and geriatrics, 46(2), 181-190.
26. Goyal, R. K., et al. (2009). Asymptomatic, small-intestinal dysmotility and bacterial overgrowth in solid organ transplant recipients. Transplantation, 88(3), 352-358.
27. Hudson, S., & Tabet, N. (2003). Acetyl-L-carnitine for dementia. The Cochrane Database of Systematic Reviews, (2).
28. Molyneux, S. L., et al. (2008). Coenzyme Q10: Is there a clinical role and a case for measurement? The Clinical Biochemist Reviews, 29(2), 71.
29. Calabrese, C., et al. (2008). Effects of a Standardized Bacopa monnieri Extract on Cognitive Performance, Anxiety, and Depression in the Elderly: A Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of Alternative and Complementary Medicine, 14(6), 707–713.
30. White, D. J., et al. (2016). The Effects of L-Theanine on Alpha-Band Oscillatory Brain Activity During a Visuo-Spatial Attention Task. Brain Topography, 29(3), 339–354.
31. Abbiati, G., et al. (1993). Absorption, tissue distribution and excretion of radiolabelled compounds in rats after administration of [14C]-L-alpha-glycerylphosphorylcholine. European journal of drug metabolism and pharmacokinetics, 18(2), 173-180.
32. FDA. (2019). Dietary Supplement Labeling Guide: Chapter IV. Nutrition Labeling.
    Ioannidis, J. P. A. (2018). The Challenge of Reforming Nutritional Epidemiologic Research. JAMA, 320(10), 969.
    Ulbricht, C., et al. (2015). An evidence-based systematic review of vitamin B12 (cobalamin) by the Natural Standard Research Collaboration. Journal of dietary supplements, 12(3), 260-294.
33. Huperzine A. (2020). In LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases.
34. Sarris, J., et al. (2015). Nutrient and herbal interactions and adverse effects associated with oral supplementation for sleep. The Journal of Alternative and Complementary Medicine, 21(3), 143-155.